- Home
- VVPR vs RPTX Comparison
VVPR vs RPTX Comparison
Compare VVPR & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVPR
- RPTX
- Stock Information
- Founded
- VVPR 2014
- RPTX 2016
- Country
- VVPR United Kingdom
- RPTX Canada
- Employees
- VVPR N/A
- RPTX N/A
- Industry
- VVPR Power Generation
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- VVPR Utilities
- RPTX Health Care
- Exchange
- VVPR Nasdaq
- RPTX Nasdaq
- Market Cap
- VVPR 62.7M
- RPTX 63.9M
- IPO Year
- VVPR 2016
- RPTX 2020
- Fundamental
- Price
- VVPR $3.69
- RPTX $1.39
- Analyst Decision
- VVPR
- RPTX Strong Buy
- Analyst Count
- VVPR 0
- RPTX 3
- Target Price
- VVPR N/A
- RPTX $4.50
- AVG Volume (30 Days)
- VVPR 1.4M
- RPTX 90.4K
- Earning Date
- VVPR 01-01-0001
- RPTX 08-05-2025
- Dividend Yield
- VVPR N/A
- RPTX N/A
- EPS Growth
- VVPR N/A
- RPTX N/A
- EPS
- VVPR N/A
- RPTX N/A
- Revenue
- VVPR $79,000.00
- RPTX $1,073,000.00
- Revenue This Year
- VVPR N/A
- RPTX N/A
- Revenue Next Year
- VVPR N/A
- RPTX N/A
- P/E Ratio
- VVPR N/A
- RPTX N/A
- Revenue Growth
- VVPR N/A
- RPTX N/A
- 52 Week Low
- VVPR $0.62
- RPTX $0.89
- 52 Week High
- VVPR $8.88
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- VVPR 40.07
- RPTX 48.49
- Support Level
- VVPR $3.60
- RPTX $1.40
- Resistance Level
- VVPR $7.20
- RPTX $1.45
- Average True Range (ATR)
- VVPR 0.72
- RPTX 0.05
- MACD
- VVPR -0.32
- RPTX -0.01
- Stochastic Oscillator
- VVPR 6.05
- RPTX 15.38
About VVPR VivoPower International PLC
Vivopower International PLC is a solar power company. It provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions, Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Electric Vehicles segment. Geographically its key revenue derives from the Netherlands.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.